TRIAL Holdings (TSE:141A) just posted a sharp rise in net sales compared to last year and received an industry award for ...

The initiative is part of a restructuring to preserve cash while the company completes the design of the robotic surgery ...

Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...

Anavex Life Sciences ( ($AVXL) ) has issued an update. On November 14, 2025, Anavex Life Sciences announced that the Committee for Medicinal ...

BrainsWay's growth remains strong, and its margins are improving as the business scales. This situation appears set to ...

Centessa Pharmaceuticals recently completed a follow-on equity offering, raising approximately US$250 million by issuing over 11.6 million American Depositary Shares at US$21.50 each, with a discount ...

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...

AI, liquidity, and cyclical growth are shaping today's top-heavy bull market. Early signs of cyclical growth are emerging.

National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.

The ASX 200 burned through five months of gains, resetting to levels last seen in July. Energy provided some support as crude ...

Objective To assess the effects of behaviourally informed short message service (SMS) reminders on demand for human ...

The ASX healthcare sector finished the week in a steady state, despite ripple effects of a sharp sell-off on Wall Street.